SY
SYNOVO GMBH
Grant-FundedCORDISEvolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform
Biotech · Deep Tech
SYNOVO GMBH is a private SME recorded in CORDIS in Germany, with participation in 11 EU research and innovation projects. Its recorded projects include “Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€4,422,442
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇩🇪Germany
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
SYNOVO GMBH is a private SME recorded in CORDIS in Germany, with participation in 11 EU research and innovation projects. Its recorded projects include “Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
BiotechDeep Tech
Tags:BiotechDeep Tech
Company Info
SYNOVO GMBH Info
Funding
EU Grants€4,422,442